Depsipeptide (FR901228) induces lysine-specific histone acetylation, differentiation and apoptosis in acute myeloid leukemia cells and demonstrates synergy with decitabine.

被引：0
|
作者：
Maghraby, EA
Murphy, T
Parthun, MR
Klisovic, M
Sklenar, A
Archer, KJ
Whitman, S
Grever, MR
Caligiuri, MA
Byrd, JC
Marcucci, G
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
434
引用
收藏
页码：103A / 104A
页数：2
相关论文
共 7 条
  • [1] The histone deacetylase inhibitor depsipeptide (FR901228) induces apoptosis via activation of the caspase 8 pathway concurrent with lysine specific acetylation in chronic lymphocytic leukemia cells.
    Aron, JL
    Murphy, T
    Parthun, MR
    Bannerji, R
    Kanakry, C
    Lucas, D
    Flinn, IW
    Marcucci, G
    Grever, MR
    Byrd, JC
    BLOOD, 2001, 98 (11) : 807A - 808A
  • [2] Phase I trial of the histone deacetylase inhibitor. Depsipeptide (FR901228) in acute myeloid leukemia (AML).
    Marcucci, G
    Bruner, RJ
    Binkley, PF
    Xiao, J
    Chan, KK
    Parthun, M
    Davis, M
    Fischer, B
    Shank, R
    Moran, M
    Byrd, JC
    Grever, M
    BLOOD, 2002, 100 (11) : 86A - 86A
  • [3] Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein
    Aron, JL
    Parthun, MR
    Marcucci, G
    Kitada, S
    Mone, AP
    Davis, ME
    Shen, TS
    Murphy, T
    Wickham, J
    Kanakry, C
    Lucas, DM
    Reed, JC
    Grever, MR
    Byrd, JC
    BLOOD, 2003, 102 (02) : 652 - 658
  • [4] The histone deacetylase inhibitor depsipeptide (FR901228) selectively induces apoptosis in latency type III Epstein-Barr virus (EBV) transformed lymphoblastoid cells (LCL) and is enhanced by the inhibition of NFkappaB.
    Roychowdhury, S
    Baiocchi, RA
    Vourganti, S
    Bhatt, D
    Chou, JD
    Eisenbeis, CF
    Grever, MR
    Caligiuri, MA
    BLOOD, 2002, 100 (11) : 780A - 781A
  • [5] Sequential 5-aza-2′-deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1
    Weiser, TS
    Guo, ZS
    Ohnmacht, GA
    Parkhurst, ML
    Tong-On, P
    Marincola, FM
    Fischette, MR
    Yu, XD
    Chen, GA
    Hong, JA
    Stewart, JH
    Nguyen, DM
    Rosenberg, SA
    Schrump, DS
    JOURNAL OF IMMUNOTHERAPY, 2001, 24 (02): : 151 - 161
  • [6] Depsipeptide induces histone acetylation and promotes apoptosis in human acute myelogenous leukemia cells with the t(8;21)(q22;q22) translocation.
    Murphy, TJ
    Shinn, C
    Grever, MR
    Byrd, JC
    BLOOD, 2000, 96 (11) : 214B - 214B
  • [7] Depsipeptide (FR228), an inhibitor of histone deacetylase activity, induces proliferation arrest and apoptosis in acute myeloid leukemia cells possibly through down-regulation of RhoA and its upstream regulator LARG.
    Liu, SJ
    Shen, TS
    Klisovic, MI
    Becknell, B
    Marcucci, G
    BLOOD, 2003, 102 (11) : 214B - 214B
1